Loading company…
MEDITAKT, based in Suita and founded in 2018, uses machine learning on clinical data to predict the effect of anti-rheumatic treatments.
Established in June 2018 and based in Suita, Japan, MEDITAKT develops predictions of anti-rheumatic treatment effects by analyzing data with machine learning.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in